Congenic strains displaying similar clinical phenotype of arthritis represent different immunologic models of inflammation

Genes and Immunity

Volumn 9, Issue 7, 2008, Pages 591-601

  Adarichev, V A ^a   Vegvari, A ^a   Szabo, Z ^a   Kis Toth, K ^a   Mikecz, K ^a   Glant, T T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BAGG ALBINO MOUSE; CELL PROLIFERATION; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; IMMUNE RESPONSE; INCIDENCE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOGLYCAN INDUCED ARTHRITIS; QUANTITATIVE TRAIT LOCUS; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CROSSES, GENETIC; FEMALE; INFLAMMATION MEDIATORS; MALE; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED DBA; MODELS, IMMUNOLOGICAL; PHENOTYPE; PROTEOGLYCANS;

MURINAE;

EID: 67651210879     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.54     Document Type: Article

References (53)

1. Lynn AH, Kwoh CK, Venglish CM, Aston CE, Chakravarti A. Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet 1995; 57 150-159.
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-37.
3. Choi S, Rho Y, Ji JD, Song GG, Lee Y. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 166-170.
4. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C et al New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-10750.
5. Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T et al Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998; 10: 1891-1895.
6. Barton A, Eyre S,Myerscough A, Brintnell B, Ward D, Ollier WE et al High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Hum Mol Genet 2001; 10: 1901-1906.
7. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J et al A genome-wide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001; 68: 927-936.
8. John S, Eyre S, Myerscough A, Barrett J, Silman A, Ollier W et al. Linkage and association analysis of candidate genes in rheumatoid arthritis. J Rheumatol 2001; 28: 1752-1755.
9. MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S et al Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 2002; 46: 632-639.
10. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C et al. Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003; 48: 906-916.
11. Osorio Y, Fortea J, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C et al. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum 2004; 50: 2757-2765.
12. Cleland LG. Animal models of rheumatoid arthritis. Br J Rheumatol 1996; 35: 1041-1042.
13. Holmdahl R. Dissection of the genetic complexity of arthritis using animal models. J Autoimmun 2003; 21: 99-103.
14. Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007; 4: E278.
15. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000; 164: 4340-4347.
16. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987; 30: 306-318.
17. Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: Immune regulation, cellular mechanisms and genetics. Crit Rev Immunol 2003; 23: 199-250.
18. Adarichev VA, Bardos T, Christodoulou S, Phillips MT, Mikecz K, Glant TT. Major histocompatibility complex controls susceptibility and dominant inheritance, but not the severity of the disease in mouse models of rheumatoid arthritis. Immunogenetics 2002; 54: 184-192.
19. Adarichev VA, Nesterovitch AB, Bardos T, Biesczat D, Chandrasekaran R, Vermes C et al. Sex effect on clinical and immunological quantitative trait loci in a murine model of rheumatoid arthritis. Arthritis Rheum 2003; 48: 1708-1720.
20. Otto JM, Cs-Szabó G, Gallagher J, Velins S, Mikecz K, Buzas EI et al. Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. Arthritis Rheum 1999; 42: 2524-2531.
21. Otto JM, Chandrasekaran R, Vermes C, Mikecz K, Finnegan A, Rickert SE et al. A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J Immunol 2000; 165: 5278-5286.
22. Glant TT, Adarichev VA. Immunogenetics of experimentally induced arthritis. In: Falus A (ed). Immunogenomics and Human Disease. John Wiley & Sons Ltd: Chichester, 2006, pp 271-297.
23. Adarichev VA, Valdez JC, Bardos T, Finnegan A, Mikecz K, Glant TT. Combined autoimmune models of arthritis reveal shared and independent qualitative (binary) and quantitative trait loci. J Immunol 2003; 170: 2283-2292.
24. Markel P, Shu P, Ebeling C, Carlson GA, Nagle DL, Smutko JS et al. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet 1997; 17: 280-284.
25. Katz D, Lehrer S, Galan O, Lachmi B, Cohen S, Inbar I et al. Unique immunomodulating properties of dimethyl dioctadecyl ammonium bromide (DDA) in experimental viral vaccines. Adv Exp Med Biol 1996; 397: 115-125.
26. Bardos T, Mikecz K, Finnegan A, Zhang J, Glant TT. T and B cell recovery in arthritis adoptively transferred to SCID mice: Antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system. J Immunol 2002; 168: 6013-6021.
27. Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer E, Glant TT. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation. Arthritis Res Ther 2005; 7: R196-R207.
28. Finnegan A, Mikecz K, Tao P, Glant TT. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999; 163: 5383-5390.
29. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987; 30: 201-212.
30. Gulko PS, Kawahito Y, Remmers EF, Reese VR, Wang JP, Dracheva SV et al. Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. Arthritis Rheum 1998; 41 2122-2131.
31. Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL et al. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum 2005; 52: 322-332.
32. Cheng LS, Chiang SL, Tu HP, Chang SJ, Wang TN, Ko AM et al. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genet 2004; 75: 498-503.
33. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004; 89: 5862-5865.
34. Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 2005; 6: 271-273.
35. Bergsteinsdottir K, Yang H-T, Pettersson U, Holmdahl R. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol 2000; 164: 1564-1568.
36. Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM. Localization of a gene for familial recurrent arthritis. Arthritis Rheum 2000; 43 2041-2045.
37. Lu S, Nordquist N, Holmberg J, Olofsson P, Pettersson U, Holmdahl R. Both common and unique susceptibility genes in different rat strains with pristane-induced arthritis. Eur J Hum Genet 2002; 10: 475-483.
38. Teuscher C, Butterfield RJ, Ma RZ, Zachary JF, Doerge RW, Blankenhorn EP. Sequence polymorphisms in chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J Immunol 1999; 163: 2262-2266.
39. Chapman K, Mustafa Z, Irven C, Carr AJ, Clipsham K, Smith A et al. Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet 1999; 65: 167-174.
40. Kizawa H, Kou I, Iida A, Sudo A, Miyamoto Y, Fukuda A et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005; 37 138-144.
41. Adarichev VA, Nesterovitch AB, Biesczat DC, Glant TT. Genome scan for arthritis genes revealed significant chromosome locus-locus interation in mouse proteoglycan-induced arthritis. Arthritis Rheum 2003; 48: S229.
42. Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Deficiency of C3 inactivator in man. J Immunol 1971; 107: 19-27.
43. Weinberg K, Parkman R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med 1990; 322: 1718-1723.
44. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330-337.
45. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53: 3020-3023.
46. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
47. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC et al. PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005; 77 567-581.
48. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005; 76: 561-571.
49. Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF et al. Genetic dissection of a rat model for rheumatoid arthritis: significant gender influences on autosomal modifier loci. Hum Mol Genet 2000; 9: 2241-2250.
50. Yang H-T, Jirholt J, Svensson L, Sundvall M, Jansson L, Pettersson U et al. Identification of genes controlling collagen-induced arthritis in mice: Striking homology with susceptibility loci previously identified in the rat. J Immunol 1999; 163: 2916-2921.
51. Karlsson J, JohannessonM, Lindvall T, Wernhoff P, Holmdahl R, Andersson A. Genetic interactions in Eae2 control collagen-induced arthritis and the CD4+/CD8+ T cell ratio. J Immunol 2005; 174: 533-541.
52. Hanyecz A, Berlo SE, Szanto S, Broeren CPM, Mikecz K, Glant TT. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum 2004; 50: 1665-1676.
53. Glant TT, Mikecz K. Proteoglycan aggrecan-induced arthritis. A murine autoimmune model of rheumatoid arthritis. Methods Mol Med 2004; 102: 313-338.